We are live on ! Find out more
IMUX icon

Immunic
IMUX

40 hedge funds and large institutions have $102M invested in Immunic in 2014 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 18 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

550% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 2

350% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 4

101% more capital invested

Capital invested by funds: $50.9M → $102M (+$51.2M)

38% more funds holding

Funds holding: 29 → 40 (+11)

Holders
40
Holders Change
+11
Holders Change %
+37.93%
% of All Funds
1.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
18
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$9.63M
2
RIM
RS Investment Management
California
+$7.18M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$5.13M
4
Deutsche Bank
Deutsche Bank
Germany
+$1.97M
5
SFM
Sphera Funds Management
Israel
+$1.58M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$547K
2
LCM
Laurion Capital Management
New York
-$241K
3
PAM
Panagora Asset Management
Massachusetts
-$78K
4
TRCT
Tower Research Capital (TRC)
New York
-$23.1K
5
AllianceBernstein
AllianceBernstein
Tennessee
-$15.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$43.6M +$9.63M +1,250 +40%
RIM
2
RS Investment Management
California
$24.2M +$7.18M +932 +63%
Vanguard Group
3
Vanguard Group
Pennsylvania
$9.11M +$5.13M +666 +269%
BFA
4
BlackRock Fund Advisors
California
$3.94M +$685K +89 +29%
Deutsche Bank
5
Deutsche Bank
Germany
$2.55M +$1.97M +256 New
SFM
6
Sphera Funds Management
Israel
$2.04M +$1.58M +205 New
State Street
7
State Street
Massachusetts
$1.99M +$554K +72 +56%
Northern Trust
8
Northern Trust
Illinois
$1.51M +$123K +16 +12%
Goldman Sachs
9
Goldman Sachs
New York
$1.46M -$547K -71 -33%
BIT
10
BlackRock Institutional Trust
California
$1.46M +$270K +35 +32%
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$1.43M +$1.11M +144 New
Geode Capital Management
12
Geode Capital Management
Massachusetts
$1.21M +$462K +60 +98%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$920K +$323K +42 +84%
Bank of America
14
Bank of America
North Carolina
$825K +$400K +52 +168%
SIM
15
Spark Investment Management
New York
$762K +$38.5K +5 +7%
DCM
16
Driehaus Capital Management
Illinois
$723K +$208K +27 +59%
Citigroup
17
Citigroup
New York
$656K +$508K +66 New
TCIM
18
TIAA CREF Investment Management
New York
$474K – – –
NFA
19
Nationwide Fund Advisors
Ohio
$464K +$285K +37 +370%
William Blair & Company
20
William Blair & Company
Illinois
$443K +$339K +44 New
BIM
21
BlackRock Investment Management
Delaware
$392K +$15.4K +2 +5%
Swiss National Bank
22
Swiss National Bank
Switzerland
$354K +$277K +36 New
California State Teachers Retirement System (CalSTRS)
23
California State Teachers Retirement System (CalSTRS)
California
$262K +$15.4K +2 +8%
UOC
24
UBS O'Connor
Illinois
$249K +$193K +25 New
Morgan Stanley
25
Morgan Stanley
New York
$245K +$185K +24 +2,400%
1
2

IMUX Hedge Fund Activity: Q4 2014 in Review

40 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q4 2014, worth a combined $102M — up 101% from $50.9M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new IMUX positions and 2 closed out — a net gain of 11 holders — while 18 added to existing stakes and 4 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $9.63M. The largest seller was Goldman Sachs, cutting an estimated $547K.

  • 40 institutional investors held Immunic (IMUX) as of Q4 2014, up from 29 in Q3 2014.
  • Funds reported $102M of Immunic stock for Q4 2014, up 101% quarter-over-quarter.
  • 13 funds opened new Immunic positions in Q4 2014 and 2 closed out, a net change of +11 holders.
  • The largest Immunic buyer in Q4 2014 was Fidelity Investments, an estimated $9.63M added.
  • The largest Immunic seller in Q4 2014 was Goldman Sachs, an estimated $547K sold.

Based on aggregated 13F filings for Q4 2014.